Search clinical trials for: Estrogen receptor positive advanced metastatic breast cancer
Total 119784 results
-
Mayo ClinicRecruitingEstrogen Receptor-Positive Breast CarcinomaUnited States
-
DualityBio Inc.BioNTech SERecruitingMetastatic Breast CancerUnited States, China, France, Australia
-
Chongqing Precision Biotech Co., LtdThe First Affiliated Hospital of Nanchang UniversityRecruitingBreast Cancer | Gastric Cancer | Lung Cancer | Cholangiocarcinoma | Colon Cancer | Pancreas Cancer | Esophagus CancerChina
-
Chongqing Precision Biotech Co., LtdShanxi Bethune HospitalRecruitingBreast Cancer | Gastric Cancer | Esophageal Cancer | Lung Cancer | Rectal Cancer | Colon Cancer | Pancreas CancerChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAnatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage 0 Breast Cancer AJCC v8 | HER2-Negative Breast Carcinoma | Estrogen Receptor-Positive Breast CarcinomaUnited States
-
Institut Paoli-CalmettesMerck KGaA, Darmstadt, Germany; National Cancer Institute, FranceNot yet recruiting
-
University of Southern CaliforniaNational Cancer Institute (NCI)Not yet recruitingTriple Negative Breast CancerUnited States
-
Shuangyue LiuNot yet recruiting
-
Myeloid TherapeuticsRecruitingEpithelial Tumors, MalignantAustralia
-
Carrick Therapeutics LimitedBerlin-Chemie AG Menarini GroupRecruitingBreast Cancer | Metastatic Breast Cancer | Locally Advanced Breast CancerUnited States, Spain, France, United Kingdom
-
Fudan UniversityRecruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | MutationChina
-
Fudan UniversityRecruitingBreast Cancer | Advanced Breast CancerChina
-
Daiichi SankyoAstraZenecaRecruiting
-
University of PittsburghRecruitingBreast CancerUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHR Positive/HER2 Low Expression Metastatic Breast CancerChina
-
Mary D ChamberlinDartmouth-Hitchcock Medical CenterNot yet recruitingMetastatic Breast Cancer
-
Artios Pharma LtdRecruitingAdvanced Solid Tumor | Metastatic Solid TumorUnited States
-
Peking UniversityNot yet recruiting
-
Hoffmann-La RocheRecruitingMetastatic Breast CancerUnited States, Korea, Republic of, Spain, Canada, Brazil, China, Singapore, India, Turkey, Argentina, Australia, Belgium, Mexico, Finland, Hong Kong, South Africa, Italy, United Kingdom, France, Poland, Taiwan, Colombia, Germany
-
NRG OncologyNational Cancer Institute (NCI)Recruiting
-
Neogene Therapeutics, Inc.RecruitingBreast Cancer | Pancreatic Adenocarcinoma | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Colorectal Carcinoma | Other Solid TumorsUnited States
-
Hoffmann-La RocheRecruitingBreast CancerKorea, Republic of, United States, Israel, Denmark, Argentina, Brazil, Germany, Mexico, Peru, Poland, Spain, Taiwan, South Africa, Netherlands, Czechia, Italy, Australia, Hungary
-
Kathy MillerGenentech, Inc.RecruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | Estrogen-receptor-low Breast CancerUnited States
-
Centro di Riferimento Oncologico - AvianoRecruitingBreast Neoplasms | Breast Diseases | Antineoplastic Agents | Aromatase Inhibitors | Neoplasms, Breast | Hormone Receptor Positive Breast Carcinoma | ESR1 Gene MutationItaly
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingPremenopausal Breast Cancer | Hormone-receptor-positive Breast Cancer | Breast Cancer Patients at Intermediate to High Risk | Ovarian Function Suppression Combined With Aromatase Inhibitor or Tamoxifen or TorimefenChina
-
Yantai Yuhuangding HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.Recruiting
-
National Taiwan University HospitalRecruitingBreast Cancer | Hormone Receptor-positive Breast Cancer | Hormone TherapyTaiwan
-
Shanghai Fosun Pharmaceutical Industrial Development...Recruiting
-
SCRI Development Innovations, LLCSeagen Inc.Recruiting
-
Spanish Breast Cancer Research GroupAstraZenecaRecruitingMetastatic Breast Cancer | Locally Advanced Breast CancerSpain
-
Dartmouth-Hitchcock Medical CenterRecruitingMetastatic Breast CancerUnited States
-
GE HealthcareLaboratory Corporation of AmericaNot yet recruiting
-
Adrienne G. WaksEli Lilly and Company; Verastem, Inc.RecruitingBreast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
Atossa Therapeutics, Inc.InClinRecruitingBreast Neoplasms | Invasive Breast Cancer | HER2-negative Breast Cancer | Estrogen-receptor-positive Breast CancerUnited States
-
Canadian Cancer Trials GroupRecruiting
-
Spanish Breast Cancer Research GroupSeagen Inc.RecruitingHER2-positive Metastatic Breast Cancer | Locally Advanced HER2 Positive Breast CarcinomaSpain
-
ProfoundBio US Co.RecruitingOvarian Cancer | Fallopian Tube Cancer | Mesothelioma | Triple Negative Breast Cancer | Endometrial Cancer | Non-small Cell Lung Cancer | Primary Peritoneal Carcinoma | Breast Adenocarcinoma | High Grade Epithelial Ovarian Cancer | Hormone Receptor-positive/Her2 Negative Breast CancerUnited States, China
-
Hebei Medical University Fourth HospitalNot yet recruiting
-
Fudan UniversityGeneQuantum Healthcare (Suzhou) Co., Ltd.RecruitingAdvanced/ Metastatic Her-2 Positive Breast CancerChina
-
AstraZenecaDaiichi SankyoRecruitingBreast Cancer | Breast Neoplasms | Neoplasm MetastasisGermany
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Hormone Receptor-Positive Breast CarcinomaUnited States, Peru
-
Immunitas TherapeuticsRecruitingFollicular Lymphoma | Colorectal Cancer | Hodgkin Lymphoma | Esophageal Cancer | Small Bowel Cancer | Burkitt Lymphoma | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Diffuse Large B Cell Lymphoma | Head and Neck Squamous Cell Carcinoma | Hormone Receptor Positive Breast Carcinoma | Cutaneous...United States
-
Tianjin Medical University Cancer Institute and...Not yet recruitingHER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy
-
Tyra Biosciences, IncRecruitingSolid Tumor | Bladder Cancer | Advanced Solid Tumor | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Solid Tumor, Adult | FGFR3 Gene Mutation | Urinary Tract Cancer | Locally Advanced Urothelial Carcinoma | Advanced Urothelial Carcinoma | Non-muscle-invasive Bladder Cancer | FGFR3 Gene Alteration | Urinary... and other conditionsAustralia, United States, France, Spain
-
Seoul National University HospitalNot yet recruitingAdvanced Breast CancerKorea, Republic of
-
Yuhan CorporationRecruitingHER2-Positive Solid TumorKorea, Republic of, Australia
-
The Affiliated Hospital of Qingdao UniversityJiangsu HengRui Medicine Co., Ltd.Not yet recruiting
-
European Organisation for Research and Treatment...Breast International Group; Menarini GroupRecruitingStage IIB Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | Stage III Breast CancerBelgium, Italy, Ireland, France, Germany
-
Olema Pharmaceuticals, Inc.NovartisRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | HR-positive Breast Cancer | HER2-negative Breast CancerUnited States, Australia
-
Jose Pablo LeoneEli Lilly and Company; Translational Breast Cancer Research Consortium (TBCRC)RecruitingMale Breast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Negative Breast CarcinomaUnited States